Lipella Pharmaceuticals Inc. Tax Credit Carryforward, Amount
Lipella Pharmaceuticals Inc. (LIPO) had Tax Credit Carryforward, Amount of $5.54 million as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2025-03-28
- 2024-12-31: Tax Credit Carryforward, Amount $5.54M.
- 2023-12-31: Tax Credit Carryforward, Amount $3.20M.
- 2022-12-31: Tax Credit Carryforward, Amount $1.26M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2024-12-31 | $5.54M 10-K · filed 2025-03-28 |
| 2023-12-31 | $3.20M 10-K · filed 2024-02-27 |
| 2022-12-31 | $1.26M 10-K · filed 2023-03-31 |